ScienceDaily

One CRISPR treatment cut “bad” cholesterol in half for a full year

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.

Por ScienceDaily

1 minuto de lectura
One CRISPR treatment cut “bad” cholesterol in half for a full year
One CRISPR treatment cut “bad” cholesterol in half for a full year

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Medical Science

Perspectivas relacionadas